| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | FLS | Common Stock | Options Exercise | +2.56K | +4% | 66.5K | Feb 15, 2022 | Direct | F1 | ||
| transaction | FLS | Common Stock | Tax liability | -$24K | -735 | -1.1% | $32.62 | 65.8K | Feb 15, 2022 | Direct | |
| transaction | FLS | Common Stock | Options Exercise | $0 | +2.71K | +4.12% | $0.00 | 68.5K | Feb 16, 2022 | Direct | |
| transaction | FLS | Common Stock | Tax liability | -$21.7K | -650 | -0.95% | $33.36 | 67.9K | Feb 16, 2022 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | FLS | Restricted Stock Units | Award | $0 | +9.17K | +40.73% | $0.00 | 31.7K | Feb 15, 2022 | Common Stock | 9.17K | Direct | F2, F3 | |
| transaction | FLS | Performance Rights | Award | $0 | +9.17K | +42.78% | $0.00 | 30.6K | Feb 15, 2022 | Common Stock | 9.17K | Direct | F4 | |
| transaction | FLS | Performance Rights | Options Exercise | $0 | -7.17K | -23.42% | $0.00 | 23.4K | Feb 15, 2022 | Common Stock | 7.17K | Direct | F1 | |
| transaction | FLS | Restricted Stock Units | Options Exercise | $0 | -2.65K | -8.37% | $0.00 | 29K | Feb 16, 2022 | Common Stock | 2.65K | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 33.3% (plus dividends accrued on the underlying shares) based on two factors during the three-year performance cycle beginning on January 1, 2019 and ending on December 31, 2021, which are: 1) the issuer's relative total shareholder return ("TSR") in comparison to the TSR averages of a predetermined compensation peer group over the performance cycle; and 2) the issuer's return on invested capital ("ROIC") measured against the issuer's targeted ROIC improvement under its operating plan. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. |
| F2 | Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. |
| F3 | The total restricted stock units beneficially owned by Mr. Gillespie has been adjusted to eliminate an inadvertent overstatement of 3,880 restricted stock units that was incorrectly included the total number of number of derivative securities beneficially owned following a February 27, 2019 reported transaction and to reflect the actual number of restricted stock units held by Mr. Gillespie following the grant reported on this Form 4. |
| F4 | Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2022 and ending on December 31, 2024 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's free cash flow ("FCF") as a percentage of net income over the entire performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. |